Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-7,966
Closed -$223K 892
2016
Q4
$223K Sell
7,966
-289
-4% -$8.09K 0.01% 681
2016
Q3
$227K Hold
8,255
0.01% 672
2016
Q2
$180K Buy
8,255
+1,043
+14% +$22.7K 0.01% 688
2016
Q1
$161K Sell
7,212
-5,011
-41% -$112K 0.01% 671
2015
Q4
$338K Sell
12,223
-211
-2% -$5.83K 0.02% 515
2015
Q3
$321K Sell
12,434
-407
-3% -$10.5K 0.02% 529
2015
Q2
$318K Buy
12,841
+914
+8% +$22.6K 0.01% 588
2015
Q1
$301K Buy
11,927
+1,563
+15% +$39.4K 0.01% 609
2014
Q4
$243K Sell
10,364
-98
-0.9% -$2.3K 0.01% 662
2014
Q3
$238K Buy
10,462
+4,022
+62% +$91.5K 0.01% 668
2014
Q2
$157K Buy
6,440
+188
+3% +$4.58K 0.01% 767
2014
Q1
$132K Sell
6,252
-38
-0.6% -$802 0.01% 725
2013
Q4
$150K Sell
6,290
-235
-4% -$5.6K 0.01% 792
2013
Q3
$140K Buy
6,525
+3,800
+139% +$81.5K 0.01% 745
2013
Q2
$54K Buy
+2,725
New +$54K ﹤0.01% 731

Other funds holding QGENF

Stephens Inc's QGENF Position: Q1 2017 in Review

Stephens Inc sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 7,966 shares — an estimated $223K sold.

Stephens Inc first reported a position in QGENF in Q2 2013 and held it in 15 quarters. The position peaked at $338K in Q4 2015. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • Stephens Inc reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • Stephens Inc sold 7,966 QIAGEN NV shares in Q1 2017, an estimated $223K.
  • Stephens Inc first reported a position in QIAGEN NV in Q2 2013 and held it in 15 quarters.
  • Stephens Inc's QIAGEN NV position peaked at $338K in Q4 2015.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on Stephens Inc's 13F filing for Q1 2017, filed 11 May 2017.